📰 Michael Secora News
Michael Secora News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Secora. Real-time updates on events, politics, business and more.
March 11, 2024
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]
March 11, 2024
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]
January 19, 2024
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CFO Michael Secora sold 25,000 shares of the business’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $10.45, for a total transaction of $261,250.00. Following the sale, the chief financial officer now directly owns 968,514 shares of the […]
November 17, 2023
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CFO Michael Secora sold 25,000 shares of the company’s stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $6.32, for a total value of $158,000.00. Following the transaction, the chief financial officer now owns 925,686 shares of the company’s […]
November 17, 2023
In a notable insider transaction, CFO Michael Secora of Recursion Pharmaceuticals Inc (NASDAQ:RXRX) sold 50,000 shares of the company's stock on November 15, 2023.
November 17, 2023
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CFO Michael Secora sold 25,000 shares of the stock in a transaction on Tuesday, November 14th. The stock was sold at an average price of $6.32, for a total value of $158,000.00. Following the sale, the chief financial officer now directly owns 925,686 shares of the company’s […]
October 13, 2023
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CFO Michael Secora sold 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, October 10th. The stock was sold at an average price of $7.07, for a total transaction of $176,750.00. Following the sale, the chief financial officer now owns 900,686 shares in […]
October 13, 2023
On October 11, 2023, Michael Secora, the Chief Financial Officer (CFO) of Recursion Pharmaceuticals Inc (NASDAQ:RXRX), sold 50,000 shares of the company.
September 11, 2023
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report)’s stock price shot up 5.6% during mid-day trading on Monday . The company traded as high as $8.55 and last traded at $8.51. 851,636 shares changed hands during trading, a decline of 73% from the average session volume of 3,192,473 shares. The stock had previously closed at […]
September 7, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!